BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4479976)

  • 1. Effect of the pretreatment with some cytostatic agents on the growth rate of leukaemia L5178Y.
    Bohunickå E; Koza I; Ujhåzy V
    Neoplasma; 1974; 21(6):659-63. PubMed ID: 4479976
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteration of SRBC immunogenicity by cytostatics (Ypenyl and Cytembena).
    Bohunická E; Ujházy V; Koza I
    Neoplasma; 1973; 20(6):695-7. PubMed ID: 4589743
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
    Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
    Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma.
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík F
    Neoplasma; 1971; 18(5):471-2. PubMed ID: 5165867
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic effectiveness of PTT-119 evaluated in vivo in experimental models].
    Bianchi R; Nardelli B; Allegrucci M; Fioretti MC
    G Ital Chemioter; 1985; 32(1):1-6. PubMed ID: 3830770
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytostatic effect of vinylogous nitrogen mustard carbonamidium salts against transplanted tumors in an automatic preliminary test and a sequential test program].
    Gutsche W; Jungstand W; Wohlrabe K; Fischer GW; Lohs K
    Arch Geschwulstforsch; 1972; 39(2):121-7. PubMed ID: 5065117
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent experimental researches on Peptichemio].
    De Barbieri A
    G Ital Chemioter; 1974; 21(1):2-4. PubMed ID: 4549578
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia.
    Zeller WJ; Schreiber J; Petru E; Eisenbrand G
    Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cytostatic alkylating agents on deoxyribonucleo protein complex of lymphatic and haemopoetic tissue.
    Matyásová J; Skalka M
    Neoplasma; 1966; 13(4):433-42. PubMed ID: 5921852
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 2. Pharmacological characterization of 2-alkylsulfonyl-oxyalkylamino-oxazaphosphorine-2-oxides including immunological reaction].
    Arzneimittelforschung; 1974 Aug; 24(8):1149-60. PubMed ID: 4371545
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of cortiphen and cyclophosphamide in uterine sarcoma induced primarily by 1,2-dimethylhydrazine and estradiol dipropionate in CBA mice].
    Merkulova IB; Vvedenskaia NA; Kiselev VI
    Eksp Onkol; 1990; 12(1):68-70. PubMed ID: 2298148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunodepressive and lympholytic action of kortifen].
    Pykhtina AA; Gladkova NE
    Farmakol Toksikol; 1988; 51(5):72-4. PubMed ID: 3208888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of several immunomodulating agents on a model of humoral and cell mediated immunity in the mouse [proceedings].
    Bruin J; Cottney J; Gemmel DK; Lewis AJ
    Br J Pharmacol; 1979 May; 66(1):67P-68P. PubMed ID: 454953
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of the immunostimulatory activity of levamisole.
    Mantovani A; Spreafico F
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:302. PubMed ID: 4859247
    [No Abstract]   [Full Text] [Related]  

  • 15. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
    Schmid FA; Hutchison DJ
    Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunosuppressive effect of various cytostatics on humoral antibody formation].
    Potel J; Brock N
    Arzneimittelforschung; 1971 Aug; 21(8):1250-4. PubMed ID: 5110029
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis, acute toxicity and chemotherapeutic anti-cancer activities of a new tripeptidic mustard.
    De Barbieri A; Dall'Asta L; Comini A; Springolo V; Mosconi P; Coppi G
    Farmaco Sci; 1983 Apr; 38(4):205-18. PubMed ID: 6861998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopharmacological studies of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative.
    Allegrucci M; Ballerini P; Romani L; Frati L
    Immunopharmacol Immunotoxicol; 1987; 9(1):71-86. PubMed ID: 3450712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bendamustine (Treanda) for CLL and NHL.
    Med Lett Drugs Ther; 2008 Nov; 50(1299):91-2. PubMed ID: 19008789
    [No Abstract]   [Full Text] [Related]  

  • 20. Preclinical studies on NSC290205 aza-steroid alkylator activity in combination with adriamycin against lymphoid leukaemia.
    Trafalis DT; Tsavdaridis D; Camoutsis C; Karayiani V; Mourelatos D; Dalezis P; Athanassiou A; Pangalis GA; Papageorgiou A
    Br J Haematol; 2005 Feb; 128(3):343-50. PubMed ID: 15667536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.